O'Byrne Jason
- SEC CIK
- 0001871145
In the past year, 3 open-market sale filings worth $68.9K and no purchases.
Current role at each company
- OLMA Olema Pharmaceuticals, Inc.CHIEF FINANCIAL OFFICERas of Sep 2, 2026
- VIR Vir Biotechnology, Inc.EVP & Chief Financial Officeras of Mar 23, 2026
- CRBU Caribou Biosciences, Inc.Chief Financial Officeras of Feb 22, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $68.9K
- 3 filings
- Net
- −$68.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists O'Byrne Jason as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VIR Vir Biotechnology, Inc.
EVP & Chief Financial Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 (view filing) | Feb 24 | 2 days | O'Byrne JasonEVP & Chief Financial Officer | SSale | −1.63K | $9.53 | −$15.6K | −1.0%162.6K after | 10b5-1 |
| Feb 24, 2026 (view filing) | Feb 23 | 1 day | O'Byrne JasonEVP & Chief Financial Officer | SSale | −2.09K | $7.45 | −$15.6K | −1.3%164.2K after | 10b5-1 |
| Nov 18, 2025 (view filing) | Nov 17 | 1 day | O'Byrne JasonEVP & Chief Financial Officer | SSale | −6.80K | $5.56 | −$37.8K | −5.8%110.7K after | 10b5-1 |